1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP | 1 |
| Barnhart, TE; Bean, J; Cai, W; Engle, JW; Feng, L; Goel, S; Hong, H; Liu, Z; Nayak, TR; Theuer, CP; Yang, K; Yang, Y; Zhang, Y | 1 |
2 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution | 2015 |
In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Cell Line, Tumor; Copper Radioisotopes; Endoglin; Graphite; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Immunoconjugates; Isotope Labeling; Mammary Neoplasms, Experimental; Mice; Molecular Imaging; Nanoconjugates; Neovascularization, Pathologic; Oxides; Positron-Emission Tomography; Receptors, Cell Surface | 2012 |